Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stromal Cells for COVID-19 Induced ARDS
NCT04345601Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Feb 2021
- Primary completion
- Jan 2023
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Provacel in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Baylor College of Medicine. Started Feb 2021; status: completed.
02
Drugs
Provacel
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04345601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04345601.